Want to see IN:MEDPLUS full AI Analyst Report?
MEDPLUS Stock Chart & Stats
₹808.80
₹1.40(0.17%)
At close: 4:00 PM EST
₹808.80
₹1.40(0.17%)
Day’s Range― - ―
52-Week Range₹627.00 - ₹1,020.35
Previous CloseN/A
Volume104.47K
Average Volume (3M)19.00K
Market Cap
₹75.89B
Enterprise Value₹108.84B
Total Cash (Recent Filing)₹6.13B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)35.6
Beta0.59
Next Earnings
Oct 27, 2026EPS Estimate
4.6Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)17.55
Shares Outstanding120,137,060
10 Day Avg. Volume18,597
30 Day Avg. Volume19,003
Financial Highlights & Ratios
PEG Ratio0.99
Price to Book (P/B)5.10
Price to Sales (P/S)1.46
P/FCF Ratio24.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)17.28
Revenue Forecast (FY)₹80.52B
Bulls Say, Bears Say
Bulls Say
Consistent Revenue ExpansionSustained revenue scaling indicates expanding business activity and a durable growth trajectory rather than reliance on a single period. Continued top-line expansion can support store and digital-channel investment, strengthen operating scale, and improve long-term earnings potential.
Improved Free Cash FlowThe recent improvement in operating and free cash flow strengthens the company’s ability to reinvest, support operations, and fund growth with internally generated resources. This represents a meaningful recovery from earlier weak cash generation and improves financial flexibility.
Growing Equity And AssetsSteady growth in equity and assets suggests the balance sheet has expanded alongside the business, providing a broader capital base for operations. Moderate debt-to-equity levels and manageable 2026 leverage offer support for continued investment, despite some rising debt reliance.
Bears Say
Thin And Volatile ProfitabilityPersistently thin net margins leave limited room to absorb cost increases, pricing pressure, or unfavorable product mix changes. The sharp 2026 gross-margin decline also signals that profitability is not yet consistently durable, increasing execution risk as revenue expands.
Rising Leverage For A Thin-margin BusinessIncreasing leverage can reduce financial flexibility when profitability is limited, because more operating cash may be needed to service debt rather than fund expansion. Greater debt reliance also makes the business more sensitive to weaker earnings or sustained margin pressure.
Inconsistent Cash ConversionAlthough recent free cash flow improved, conversion below net income in 2026 indicates that working-capital or reinvestment demands continue to absorb part of reported earnings. If this pattern persists, internally generated cash may be less predictable for growth and obligations.
MedPlus Health Services Ltd. News
MEDPLUS FAQ
What was MedPlus Health Services Ltd.’s price range in the past 12 months?
MedPlus Health Services Ltd. lowest stock price was ₹627.00 and its highest was ₹1020.35 in the past 12 months.
What is MedPlus Health Services Ltd.’s market cap?
MedPlus Health Services Ltd.’s market cap is ₹75.89B.
When is MedPlus Health Services Ltd.’s upcoming earnings report date?
MedPlus Health Services Ltd.’s upcoming earnings report date is Oct 27, 2026 which is in 17 days.
How were MedPlus Health Services Ltd.’s earnings last quarter?
MedPlus Health Services Ltd. released its earnings results on Jul 21, 2026. The company reported ₹2.8 earnings per share for the quarter, beating the consensus estimate of ₹1.95 by ₹0.85.
Is MedPlus Health Services Ltd. overvalued?
According to Wall Street analysts MedPlus Health Services Ltd.’s price is currently Overvalued.
Does MedPlus Health Services Ltd. pay dividends?
MedPlus Health Services Ltd. does not currently pay dividends.
What is MedPlus Health Services Ltd.’s EPS estimate?
MedPlus Health Services Ltd.’s EPS estimate is 4.6.
How many shares outstanding does MedPlus Health Services Ltd. have?
MedPlus Health Services Ltd. has 120,137,060 shares outstanding.
What happened to MedPlus Health Services Ltd.’s price movement after its last earnings report?
MedPlus Health Services Ltd. reported an EPS of ₹2.8 in its last earnings report, beating expectations of ₹1.95. Following the earnings report the stock price went down -0.693%.
Which hedge fund is a major shareholder of MedPlus Health Services Ltd.?
Currently, no hedge funds are holding shares in IN:MEDPLUS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
MedPlus Health Services Ltd.
MedPlus Health Services Limited operates primarily as an Indian retailer of pharmaceutical products and diverse general merchandise. Its extensive product catalog includes vital health and wellness items such as prescription medications, vitamins, medical equipment, and diagnostic kits, alongside everyday essentials like toiletries, baby care products, cleaning supplies, and sanitizers. Beyond its retail footprint, the company also offers wholesale cash-and-carry services, comprehensive pathological laboratory testing, and contract manufacturing for its own-brand pharmaceutical goods. By March 31, 2021, MedPlus had established a substantial presence with 1,659 brick-and-mortar stores situated in the Indian states of Karnataka, Tamil Nadu, Telangana, and Andhra Pradesh, complemented by its online store. This Hyderabad-based company was incorporated in 2006.
Technical Analysis
Krsnaa Diagnostics Limited
―
Dr. Lal PathLabs Limited
―
Metropolis Healthcare Ltd.
―
Sastasundar Ventures Limited
―
Thyrocare Technologies Ltd
―